Literature DB >> 24773559

Risk factors for post-traumatic massive cerebral infarction secondary to space-occupying epidural hematoma.

Wen-hao Wang1, Lian-shui Hu, Hong Lin, Jun Li, Fei Luo, Wei Huang, Jun-ming Lin, Gen-ping Cai, Chang-chun Liu.   

Abstract

Post-traumatic massive cerebral infarction (MCI) is a fatal complication of concurrent epidural hematoma (EDH) and brain herniation that commonly requires an aggressive decompressive craniectomy. The risk factors and surgical indications of MCI have not been fully elucidated. In this retrospective study, post-traumatic MCI was diagnosed in 32 of 176 patients. The performance of a decompressive craniectomy simultaneously with the initial hematoma-evacuation surgery improved their functional outcomes, compared with delayed surgery (on the 6-month Extended Glasgow Outcome Scale, 5.6±1.5 vs. 3.4±0.6; p<0.001). Significantly increased risks for MCI were observed in patients with an EDH at a transtemporal location (adjusted odds ratio [OR], 16.48; p=0.003), an EDH larger than 100 mL in volume (OR, 7.04; p=0.001), preoperative shock for longer than 30 min (OR, 13.78; p=0.002), bilateral mydriasis (OR, 7.08; p=0.004), preoperative brain herniation for longer than 90 min (OR, 6.41; p<0.001), and a Glasgow Coma Score of 3-5 points (OR, 2.86; p<0.053). Multi-variate logistic regression analysis revealed no significant association between post-traumatic MCI and age, gender, mid-line shift, Rotterdam computed tomography score, intraoperative hypotension, or serum concentrations of sodium or glucose. Incidence of post-traumatic MCI increased from 16.4% in those having any two of the six risk factors to 47.7% in those having any three or more of the six risk factors (p<0.001). Patients with concurrent EDH and brain herniation exhibited an increased risk for post-traumatic MCI with the accumulation of several critical clinical factors. Early decompressive craniectomy based on accurate risk estimation is recommended in efforts to improve patient functional outcomes.

Entities:  

Keywords:  brain herniation; cerebral infarction; craniotomy; decompressive craniectomy; epidural hematoma

Mesh:

Year:  2014        PMID: 24773559     DOI: 10.1089/neu.2013.3142

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  6 in total

1.  Postoperative cerebral infarction after evacuation of traumatic epidural hematoma in children younger than two years: Single-center experience.

Authors:  Mohammed Fathy Adel Ali; Mohammad Elbaroody; Mohamed F M Alsawy; Ahmed El Fiki; Ehab El Refaee; Hesham A Elshitany
Journal:  Surg Neurol Int       Date:  2022-04-15

Review 2.  Traumatic Epidural and Subdural Hematoma: Epidemiology, Outcome, and Dating.

Authors:  Mariarosaria Aromatario; Alessandra Torsello; Stefano D'Errico; Giuseppe Bertozzi; Francesco Sessa; Luigi Cipolloni; Benedetta Baldari
Journal:  Medicina (Kaunas)       Date:  2021-02-01       Impact factor: 2.430

Review 3.  The prevalence and risk factors of posttraumatic cerebral infarction in patients with traumatic brain injury: a systematic review and meta-analysis.

Authors:  Chen Zhi-Ling; Li Qi; Yang Jun-Yong; Yuan Bang-Qing
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

4.  Treatment of intracranial hemorrhage with neuroendoscopy guided by body surface projection.

Authors:  Shengli Qiu; Tao Liu; Guanghui Cao; Kun Wu; Tingsheng Zhao
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

5.  Comparative effectiveness of different surgical procedures for traumatic acute epidural haematoma: study protocol for Prospective, Observational Real-world Treatments of AEDH in Large-scale Surgical Cases (PORTALS-AEDH).

Authors:  Chun Yang; Jiyuan Hui; Li Xie; Junfeng Feng; Jiyao Jiang
Journal:  BMJ Open       Date:  2022-03-09       Impact factor: 2.692

6.  Prospective Randomized Evaluation of Decompressive Ipsilateral Craniectomy for Traumatic Acute Epidural Hematoma (PREDICT-AEDH): study protocol for a randomized controlled trial.

Authors:  Chun Yang; Xianjian Huang; Junfeng Feng; Li Xie; Jiyuan Hui; Weiping Li; Jiyao Jiang
Journal:  Trials       Date:  2021-06-29       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.